Dick Wågsäter
Immune cell activation and vascular remodellilng in aortic aneurysm
Cardiovascular disease, including abdominal aortic aneurysm (AAA), is an enormous health care burden and ruptured AAA account for approximately 200,000 of annual deaths. AAA is an inflammatory disease and despite long-term anti-inflammatory and lipid lowering treatment due to other underlying vascular disease the majority of AAA patients have, these drugs neither prevent nor inhibit aneurysm disease. Not a single drug treatment for aneurysm exist. This indicates that more specific immune cell targeting is required to inhibit aneurysm development.
To be able to find new therapeutic preventive strategies the molecular mechanisms behind the disease and drug targets needs to be elucidated in more detail. Based on our previous studies we have identified several key factors that could be targeted by certain drugs. The main aim of my research is to clarify pathophysiological and molecular mechanisms behind AAA disease and to find novel treatment strategies and biomarkers for prediction and prognosis.
Human samples, cell and in vivo models of aneurysm disease is used in a translational approach to target novel pathways, immune cell activation and vascular remodelling via transcriptional regulation and by targeting glycolysis using various drugs. The knowledge is returned back to the clinic where we together with the clinicians test drugs in clinical trials and analyze biomarkers in the follow-up.
The importance of my research is to increase the knowledge of pathogenesis of AAA so that standardized surgery can be replaced by individual risk -adapted medication resulting in reduced mortality and fewer complications leading to better quality of life.
Besides the main research focus on AAA my research also focuses on other cardiovascular disease as well as identifying biomarkers, investigating mechanisms and functional studies in colorectal cancer.
Post doc opportunity: Candidates with a strong research track are welcome to contact me for a post doc.
Publications
Emerging role and clinical implication of mRNA scavenger decapping enzyme in colorectal cancer
Part of Pathology, Research and Practice, 2024
Part of In Vivo, p. 1775-1782, 2024
Part of Nucleosides, Nucleotides & Nucleic Acids, p. 807-817, 2023
Association of IL-10 and CRP with Pulse Wave Velocity in Patients with Abdominal Aortic Aneurysm
Part of Journal of Clinical Medicine, 2022
Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
Part of World Journal of Gastroenterology, p. 2148-2151, 2022
Part of Atherosclerosis, p. 68-69, 2022
Preclinical evaluation of [C-11]GW457427 as a tracer for neutrophil elastase
Part of Nuclear Medicine and Biology, p. 62-71, 2022
Increased mortality in the A/A genotype of the SNP rs28372698 of interleukin 32
Part of Experimental and Therapeutic Medicine, 2021
Part of World Journal of Gastroenterology, p. 5076-5087, 2021
Part of In Vivo, p. 969-975, 2021
Part of ESC Heart Failure, p. 3865-3874, 2021
Part of Annals of Vascular Surgery, p. 425-433, 2021
- DOI for Metformin Prescription Associated with Reduced Abdominal Aortic Aneurysm Growth Rate and Reduced Chemokine Expression in a Swedish Cohort
- Download full text (pdf) of Metformin Prescription Associated with Reduced Abdominal Aortic Aneurysm Growth Rate and Reduced Chemokine Expression in a Swedish Cohort
Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E-deficient mice
Part of JVS-Vascular Science, p. 33-42, 2021
Circulating microRNA in patients with popliteal and multiple artery aneurysms.
Part of JVS-vascular science, p. 129-135, 2021
A histopathological classification scheme for abdominal aortic aneurysm disease
Part of JVS-Vascular Science, p. 260-273, 2021
Part of Vascular pharmacology, 2021
Part of Journal of the American Heart Association, 2021
- DOI for Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression
- Download full text (pdf) of Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression
Part of Molecular Medicine Reports, p. 4629-4636, 2020
- DOI for Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7-year follow-up of a healthy community-living elderly population
- Download full text (pdf) of Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7-year follow-up of a healthy community-living elderly population
Altered IL-32 Signaling in Abdominal Aortic Aneurysm
Part of Journal of Vascular Research, p. 236-244, 2020
Part of BMC Medical Genetics, 2020
Part of BIOMEDICAL REPORTS, p. 3-10, 2019
Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer
Part of Anticancer Research, p. 4933-4940, 2019
Part of International Journal of Molecular Medicine, p. 471-478, 2018